Skip to main
University-wide Navigation

Active Trials by Group

A donut graph displaying "Oncology MCC 68%" and "Non Oncology 32%"

Active Protocols by Department

A bar graph displaying various department names and values. The highest is Markey Cancer Center with 614.

While a majority of the research is conducted through MCC, the CRSO supports study teams in more than 32 departments across the institution.

So far in 2026:

2,323 Total Active Studies eIRB

972 Total Active Protocols CTMS

7,167 Active Subjects*

860 New Subjects Consented


Clinical Research Growth and CRSO Impact Over Time

a line graph showing the amount of IRB approvals and New Protocols in CTMS from 2021 to 2025

 

New Activity Year over Year Growth Rates (2025)
IRB Submissions +23.1%
Protocols in CTMS +57.2%

In 2025, the CRSO captured significant growth in new research activity, with a 23% increase in new IRB submissions and a 57% increase in new protocols built in CTMS compared to the prior year. This demonstrates the office's critical role in supporting and onboarding new clinical research across the institution.